Med-El Founders Receive Queen Elizabeth Prize for Engineering
The 2026 award recognizes Ingeborg and Erwin Hochmair for their contributions to cochlear implant technology.
The 2026 award recognizes Ingeborg and Erwin Hochmair for their contributions to cochlear implant technology.
The FDA has approved an expanded indication for Med-El cochlear implants for children seven months and older with bilateral sensorineural hearing loss.
The partnership makes the bimodal neuromodulation device for tinnitus available through clinics in Philadelphia and Charlotte.
Summary:Sonitus Medical and BHM have formed a strategic partnership to globally commercialize...
A recent study of outcomes in infants and young deaf children with cochlear implants suggests that socioeconomic status plays a major role in whether spoken language becomes their primary communication mode.
Envoy Medical received FDA approval to begin a study of its fully implanted CI, which uses the ear’s natural anatomy to capture sound.